Femme et Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
To determine the safety of repeat doses of intravenous (IV) infusion of forodesine in patients with B-ALL, which under WHO Guidelines is now referred to as precursor B-lymphoblastic leukemia/lymphoma.
Critère d'inclusion
- B-cell acute lymphoblastic leukemia (B-ALL), which under WHO Guidelines is now referred to as precursor B-lymphoblastic leukemia/lymphoma